Lupin launches tolvaptan tablets in the US with 180-day exclusivity
Following the recent approval received from the United States Food and Drug Administration (FDA), global pharma major Lupin Limited (Lupin) announced the launch of tolvaptan tablets, 15 mg, 30 mg, 45 mg, 60 mg, and 90 mg in the United States. Lupin holds …